Irish solicitors to take on US drug firm
According to analysts, Merck's Vioxx liability is likely to reach $38 billion (€28.1bn) and could go as high as $50bn (€37bn).
Last September, Merck announced a worldwide withdrawal of its arthritis and pain medication Rofecoxib, sold under the brand name Vioxx (or Ceoxx), because a study showed an increased risk of heart attack and stroke.